Korea Institute of Toxicology Implementing Xybion's Pristima™

Share Article

Enterprise system will facilitate most complex toxicology study designs in South Korea

this upgrade and expansion of deployed modules at KIT further exemplifies the advantages of a completely integrated system that has more built-in functionality and business intelligence than any other product on the market.

Xybion Medical Systems, a world leader in preclinical data management solutions and the developer of Pristima™ the premier preclinical solution on the market, is pleased to announce that Korea Institute of Toxicology (KIT) is upgrading to Pristima at its facilities in Daejeon and Jeongeup, South Korea.    

Since 2002, KIT has been a Xybion client and has used Xybion's previous PATH/TOX SYSTEM suite as an integral business driver; using the system to plan, collect, manage and report all of its General Toxicology data. With this upgrade, KIT has expanded its software licenses to include the Pharmacy and Reproductive Toxicology modules so as to implement the full Pristima suite to cover all of its toxicology studies. With this system upgrade and expansion, KIT also chose to license Xybion's standard validation package to expedite the project and provide for a solid validation project.

Dr. Pradip Banerjee, Xybion's CEO, stated that "this upgrade and expansion of deployed modules at KIT further exemplifies the advantages of a completely integrated system that has more built-in functionality and business intelligence than any other product on the market."

The Daejeon and Jeongeup sites together comprise of over 500,000 square feet of facility space so KIT is the largest, most well-known GLP facility in South Korea and serves markets all over the world. With a vast experience in all study types, combined with highly automated procedures and reporting capabilities, KIT can define, perform and report client studies in record time and with the highest of quality. PATH/TOX SYSTEM and now Pristima, serve to capture and integrate all of the preclinical data at KIT while serving to enforce SOP's, prevent errors and summarize the results.

Myung-Sang Kwon (President) of Korea Toxicology Institute stated "we are very anxious to start using the Pristima system since our evaluation process revealed that it will facilitate our most complex study designs. It seems that Pristima is designed specifically to take into consideration the most modern concepts in toxicology study design and KIT has always been at the forefront of the best scientific approaches."

About Korea Institute of Toxicology
Korea Institute of Toxicology (KIT) is a world-class prestigious non-clinical contract research organization located in South Korea. KIT's GLP system has been certified by Korean and international regulatory authorities based on OECD and US FDA GLP criteria. Also, KIT is the first organization in Asia accredited by AAALAC International. KIT offers a full range of non-clinical research with high scientific standard and competitive pricing. (http://www.kitox.re.kr/eng/)

About Xybion Medical Systems - Xybion is the enterprise system partner of choice for life sciences product companies and research organizations worldwide. In addition to Pristima, Xybion provides professional services, consulting, training and validation activities to clients throughout the world. (http://www.xybion.com)

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Carlos Frade
Visit website